TripSitter Clinic Ltd (UY00) Ratios

2 Followers

TripSitter Clinic Ltd Ratios

DE:UY00's free cash flow for Q1 2025 was C$0.00. For the 2025 fiscal year, DE:UY00's free cash flow was decreased by C$ and operating cash flow was C$0.00. See a summary of the company’s cash flow.

Ratios	TTM	Apr 24	Jan 24	Jan 23	Jan 22
Liquidity Ratios
Current Ratio	―	<0.01	<0.01	0.18	7.38
Quick Ratio	―	<0.01	<0.01	0.18	7.38
Cash Ratio	―	<0.01	<0.01	0.10	6.57
Solvency Ratio	―	-0.01	-0.42	-2.99	-212.57
Operating Cash Flow Ratio	―	-0.06	0.00	0.00	0.00
Short-Term Operating Cash Flow Coverage	―	-0.14	0.00	0.00	0.00
Net Current Asset Value	C$ ―	C$ -747.37K	C$ -727.74K	C$ -449.55K	C$ 1.26M
Leverage Ratios
Debt-to-Assets Ratio	―	283.96	96.65	1.34	0.09
Debt-to-Equity Ratio	―	-0.45	-0.38	-0.30	0.11
Debt-to-Capital Ratio	―	-0.83	-0.60	-0.42	0.10
Long-Term Debt-to-Capital Ratio	―	0.00	0.00	0.00	0.00
Financial Leverage Ratio	―	>-0.01	>-0.01	-0.22	1.16
Debt Service Coverage Ratio	―	-0.03	-1.28	-13.87	-1.64
Interest Coverage Ratio	―	0.00	0.00	0.00	1.36
Debt to Market Cap	―	1.28	1.64	0.15	0.00
Interest Debt Per Share	―	0.05	0.04	0.02	0.53
Net Debt to EBITDA	―	-35.23	-0.78	-0.04	0.11
Profitability Margins
Gross Profit Margin	―	0.00%	-33.65%	28.41%	-635.85%
EBIT Margin	―	0.00%	-2493.62%	-381.04%	-2607.52%
EBITDA Margin	―	0.00%	-2493.62%	-379.34%	-11717.36%
Operating Profit Margin	―	0.00%	-2493.62%	-379.34%	24721.98%
Pretax Profit Margin	―	0.00%	-2181.49%	-382.75%	-11717.35%
Net Profit Margin	―	0.00%	-2181.49%	-382.75%	-29937.02%
Continuous Operations Profit Margin	―	0.00%	-2181.49%	-382.75%	-11717.35%
Net Income Per EBT	―	100.00%	100.00%	100.00%	255.49%
EBT Per EBIT	―	6.78%	87.48%	100.90%	-47.40%
Return on Assets (ROA)	―	-803.18%	-10791.61%	-1882.73%	-1791.76%
Return on Equity (ROE)	―	1.29%	41.89%	415.74%	-2072.80%
Return on Capital Employed (ROCE)	―	18.95%	47.89%	412.03%	1711.72%
Return on Invested Capital (ROIC)	―	34.74%	76.64%	586.07%	1711.72%
Return on Tangible Assets	―	-803.18%	-10791.61%	-1882.73%	-1791.76%
Earnings Yield	―	-3.61%	-183.15%	-205.67%	-52.24%
Efficiency Ratios
Receivables Turnover	―	0.00	0.00	32.44	1.47
Payables Turnover	―	0.00	0.04	0.86	3.37
Inventory Turnover	―	0.00	0.00	0.00	0.00
Fixed Asset Turnover	―	0.00	0.00	0.00	0.00
Asset Turnover	―	0.00	4.95	4.92	0.06
Working Capital Turnover Ratio	―	0.00	-0.02	1.21	0.09
Cash Conversion Cycle	―	0.00	-8.58K	-414.80	139.67
Days of Sales Outstanding	―	0.00	0.00	11.25	248.13
Days of Inventory Outstanding	―	0.00	0.00	0.00	0.00
Days of Payables Outstanding	―	0.00	8.58K	426.05	108.45
Operating Cycle	―	0.00	0.00	11.25	248.13
Cash Flow Ratios
Operating Cash Flow Per Share	―	>-0.01	0.00	0.00	0.00
Free Cash Flow Per Share	―	>-0.01	0.00	0.00	0.00
CapEx Per Share	―	<0.01	0.00	0.00	0.00
Free Cash Flow to Operating Cash Flow	―	1.00	0.00	0.00	0.00
Dividend Paid and CapEx Coverage Ratio	―	-11.63K	0.00	0.00	0.00
Capital Expenditure Coverage Ratio	―	-11.63K	0.00	0.00	0.00
Operating Cash Flow Coverage Ratio	―	-0.14	0.00	0.00	0.00
Operating Cash Flow to Sales Ratio	―	0.00	0.00	0.00	0.00
Free Cash Flow Yield	―	-17.47%	0.00%	0.00%	0.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-28.57	-0.55	-0.49	-1.91
Price-to-Sales (P/S) Ratio	―	0.00	11.91	1.86	573.03
Price-to-Book (P/B) Ratio	―	-0.36	-0.23	-2.02	39.68
Price-to-Free Cash Flow (P/FCF) Ratio	―	-5.73	0.00	0.00	0.00
Price-to-Operating Cash Flow Ratio	―	-5.73	0.00	0.00	0.00
Price-to-Earnings Growth (PEG) Ratio	―	0.29	<0.01	<0.01	>-0.01
Price-to-Fair Value	―	-0.36	-0.23	-2.02	39.68
Enterprise Value Multiple	―	-62.96	-1.25	-0.53	-4.78
Enterprise Value	―	604.75K	436.67K	987.38K	48.82M
EV to EBITDA	―	-62.96	-1.25	-0.53	-4.78
EV to Sales	―	0.00	31.25	2.02	559.67
EV to Free Cash Flow	―	-13.00	0.00	0.00	0.00
EV to Operating Cash Flow	―	-13.00	0.00	0.00	0.00
Tangible Book Value Per Share	―	-0.11	-0.11	-0.07	0.04
Shareholders’ Equity Per Share	―	-0.11	-0.11	-0.07	0.04
Tax and Other Ratios
Effective Tax Rate	―	0.00	0.00	0.00	-1.55
Revenue Per Share	―	0.00	<0.01	0.08	<0.01
Net Income Per Share	―	>-0.01	-0.05	-0.31	-0.86
Tax Burden	―	1.00	1.00	1.00	2.55
Interest Burden	―	1.00	0.87	1.00	4.49
Research & Development to Revenue	―	0.00	0.22	0.59	3.28
SG&A to Revenue	―	0.00	25.27	2.72	23.94
Stock-Based Compensation to Revenue	―	0.00	0.00	0.00	0.00
Income Quality	―	4.84	0.00	0.00	0.00

Currency in CAD